؉ levels preceded both increases in ⌬⌿m and DNA ladder formation. Inhibitors of NAD(P)H oxidase prevented TAS-103-induced apoptosis, suggesting that NAD(P)H oxidase is the primary enzyme mediating H 2 O 2 formation. Expression of the antiapoptotic protein, Bcl-2, in BJAB cells drastically inhibited TAS-103-induced apoptosis, confirming that H 2 O 2 generation occurs upstream of mitochondrial permeability transition. Therefore, these findings indicate that DNA cleavage by TAS-103 induces PARP hyperactivation and subsequent NAD ؉ depletion, followed by the activation of NAD(P)H oxidase. This enzyme mediates O 2 ؊ -derived H 2 O 2 generation, followed by the increase in ⌬⌿m and subsequent caspase-3 activation, leading to apoptosis.
؊
-derived H 2 O 2 generation, followed by the increase in ⌬⌿m and subsequent caspase-3 activation, leading to apoptosis.
A number of anticancer drugs exert their effects by inducing apoptosis (1, 2). The major apoptotic pathways act either through the induction of death receptors or the loss of mitochondrial membrane integrity (1, 2) ; the majority of anticancer drugs induce apoptosis via the mitochondrial pathway (2) . DNA is the molecular target for many of the drugs that are used in cancer therapeutics (3) . DNA damage may cause perturbations in inner mitochondrial membrane permeability (4 -7) . A sudden increase in mitochondrial membrane permeability, so-called mitochondrial permeability transition (MPT), 1 is a central coordination event in the apoptotic process (4, 8 -10) . Opening MPT pores mediates disruption of mitochondrial membrane potential (⌬⌿m) (11) . MPT causes the release of cytochrome c from mitochondria; cytochrome c then activates effector caspases to induce DNA ladder formation. Exogenous and endogenous reactive oxygen species (ROS), such as H 2 O 2 and O 2 Ϫ (11), cause apoptosis through MPT (11) (12) (13) ; some anticancer drugs induce ROS formation in apoptosis (7, 14 -17) . However, the mechanism of ROS formation by anticancer drugs remains to be clarified.
TAS-103 ( Fig. 1) , a new quinoline derivative, induces DNA cleavage through the inhibition of DNA topoisomerases I and II (18 -20) . Recently, TAS-103 is classified as a topoisomerase II-targeted drug (19) . Alteration in the topology of DNA by intercalation of TAS-103 results in inhibition of topoisomerase I-catalyzed DNA relaxation (21) . The anticancer activity of TAS-103 has a broad spectrum. The cytotoxicity of TAS-103 (IC 50 : 0.0030 -0.23 M) is much greater against various tumor cell lines than etoposide and comparable with SN-38, an active metabolite of irinotecan (CPT-11) (22) . Due to this potent cytotoxicity at low concentrations, TAS-103 must have specific inhibitory effects on topoisomerases. TAS-103 is therefore expected to be a novel and promising anticancer drug, currently under clinical evaluation in the United States (23) . Although good evidence exists that TAS-103 induces apoptosis (24, 25) , the mechanisms of TAS-103 governing this induction remain unclear.
Here, we sought to analyze the mechanism of apoptosis induction by anticancer drugs through the generation of ROS. We investigated apoptosis induction by TAS-103 in HL-60 cells and HP100 cells, H 2 O 2 -resistant cells derived from HL-60. Apoptosis was analyzed by examining DNA cleavage, DNA ladder formation, NAD ϩ depletion, H 2 O 2 generation, mitochondrial membrane potential (⌬⌿m) change, and caspase-3 activation. The mechanism of TAS-103-induced H 2 O 2 generation was examined by using inhibitors of poly(ADP-ribose) polymerase (PARP) and NAD(P)H oxidase. Moreover, to clarify whether H 2 O 2 generation via NAD(P)H oxidase occurs upstream or downstream of the MPT, we examined the effect of the expression of Bcl-2 on TAS-103-induced apoptosis in the human B cell line, BJAB cells.
EXPERIMENTAL PROCEDURES

Materials-TAS-103
-c] quinolin-7-one dihydrochloride) was provided by Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan). Proteinase K was obtained from Merck (Darmstadt, Germany). 2Ј,7Ј-Dichlorofluorescin diacetate (DCFH-DA) and 3,3Ј-dihexyloxacarbocyanine iodide (DiOC 6 (3)) were purchased from Molecular Probes (Eugene, OR). Ac-Asp-Glu-Val-Asp-7-amino-4-trifluoromethyl coumarin (DEVD-AFC), 4-amino-1,8-naphthalimide (ANI), and diphenyleneiodonium chloride (DPI) were provided by Biomol (Plymouth Meeting, PA). 6(5H)-Phenanthridinone (PHEN) and allopurinol (ALLO) were obtained from Wako Pure Chemical Industries Ltd. (Osaka, Japan). Apocynin (APO) was purchased from Nacalai Tesque, Inc. (Kyoto, Japan).
Cell Culture and Treatment with TAS-103-HP100 cells were created from HL-60 cells by repeated exposure to 100 M H 2 O 2 . The outgrowth of viable cells resulted in HP100 cells, ϳ340-fold more resistant to H 2 O 2 than the parental line, HL-60 (26) . Catalase activity in HP100 cells is increased to 18-fold higher levels than seen in HL-60 cells. HL-60 and HP100 cells were grown in RPMI 1640 supplemented with 6% fetal calf serum (FCS) at 37°C under 5% CO 2 in a humidified atmosphere. The cells (1 ϫ 10 6 cells/ml) were then treated with the indicated concentrations of TAS-103. Cells were preincubated with either PARP inhibitors or NAD(P)H oxidase inhibitors for 0.5 h where indicated.
Production of BJAB Cells Transfected with the Bcl-2 Gene-To investigate whether or not the Bcl-2 protein can modulate TAS-103-induced apoptosis, we used the human B cell line, BJAB, transfected with the Bcl-2 gene. BJAB cells were grown in RPMI 1640 medium supplemented with 6% FCS. The BJAB cells were co-transfected with the pCAGGS plasmid carrying the Bcl-2 gene and the PCMVneo plasmid carrying the neomycin-phosphotransferase resistance gene (BJAB/ Bcl-2 cells) using an Effectene Transfection Reagent (Qiagen). The pCAGGS plasmid was a gift from Dr. Yoshihide Tsujimoto (Osaka University). The cells carrying the neomycin-phosphotransferase gene without the Bcl-2 gene (BJAB/neo cells) were produced by a similar method. Transfected cells were selected in RPMI 1640 containing 6% FCS and 0.5 mg/ml G418 for 2-3 weeks. The cells (0.5 ϫ 10 6 cells/ml) were then treated with the indicated concentrations of TAS-103 for 24 h.
Detection of Cellular DNA Cleavage Induced by TAS-103-Following treatment with TAS-103, cells were washed twice with phosphatebuffered saline (PBS). Cell suspensions were solidified with agarose, followed by treatment with proteinase K as described previously (27) . Electrophoresis was performed at 14°C using a CHEF-DRII pulsed field electrophoresis system (Bio-Rad) at 200 V. Switch time was 60 s for 15 h followed by 90 s for 9 h.
Detection of Apoptosis Induced by TAS-103-For DNA ladder formation analysis by treatment with TAS-103, cells were washed twice with PBS. Cells (2 ϫ 10 6 cells), resuspended in 1 ml of cytoplasm extraction buffer (10 mM Tris (pH 7.5), 150 mM NaCl, 5 mM MgCl 2 , and 0.5% Triton X-100), were centrifuged at 1000 ϫ g for 5 min at 4°C. The cellular pellet was resuspended in lysis buffer [10 mM Tris (pH 7.5), 400 mM NaCl, and 1 mM EDTA) and centrifuged 12,000 ϫ g for 10 min at 4°C.
The supernatant was then treated overnight with 0.2 mg/ml RNase at room temperature, followed by treatment with proteinase K as described previously (28) . DNA ladder formation was analyzed by conventional electrophoresis. For the morphologic analysis, cells were treated with TAS-103, stained with acridine orange. The stained cells were observed by fluorescence microscopy.
Flow Cytometric Detection of Peroxide and ⌬⌿m in Cells Treated with TAS-103-To evaluate cellular peroxide levels, TAS-103-treated cells were incubated with 5 M DCFH-DA for 30 min at 37°C (29) . To assess changes in ⌬⌿m, TAS-103-treated cells were incubated with 40 nM DiOC 6 (3) for 15 min at 37°C (30) . Cells were then washed twice with PBS. Following resuspension in PBS, the cells were analyzed on a flow cytometer (FACScan; Becton Dickinson, San Jose, CA). Dead cells and debris were excluded from the analysis. The data were analyzed using the data analysis program, Cell Quest (BD PharMingen).
Measurement of Caspase-3 Activity-To analyze caspase-3 activity, TAS-103-treated cells (1 ϫ 10 6 cells) were washed twice with PBS and resuspended in a 100 l solution containing 0.1 M HEPES (pH 7.4), 2 mM dithiothreitol, 0.1% CHAPS, and 1% sucrose. Cell suspensions were first frozen in liquid nitrogen and then thawed at 37°C. This freezethaw procedure was repeated three times. Cell lysates were then centrifuged at 18,500 ϫ g for 15 min, to obtain the apoptotic extracts. The reaction was initiated by the addition of 20 M DEVD-AFC, a caspase-3 substrate, to 50 l of the apoptotic extract at 37°C. Product formation was measured using a Shimadzu RF-5300PC spectrofluorometer (Kyoto, Japan) with excitation at 400 nm and emission at 505 nm (31) .
Measurement of Intracellular NAD ϩ and NADP ϩ Levels-After treatment with TAS-103, cells (2 ϫ 10 6 cells) were washed twice in PBS and then resuspended in 50 l PBS. To determine NAD ϩ and NADP ϩ levels, cell suspensions were extracted in 25 l of cold 3 M perchloric acid. The cells were homogenized for 5 s using a microhomogenizer. The solution was neutralized in 2 M KOH containing 0.3 N MOPS. Following centrifugation at 3000 ϫ g for 10 min, NAD ϩ and NADP ϩ levels were analyzed by HPLC with a Shimadzu photodiode array UV detector (SPD-M10A, Kyoto, Japan) as described by Litt et al. (32) .
Measurement of Intracellular Glutathione (GSH) Level-After treatment with TAS-103, cells were washed twice with PBS. Cells (1 ϫ 10 6 cells) were resuspended in 1 ml cytoplasm extraction buffer, followed by treatment with trifluoroacetic acid according to the method as described previously (33) . The GSH level was analyzed by HPLC with an Eicom electrochemical detector (ECD-300, Kyoto, Japan) with a gold disk electrode that can detect GSH (33, 34) .
RESULTS
DNA Cleavage and DNA Ladder Formation in HL-60 and HP100 Cells Treated with TAS-103-
We analyzed DNA strand breaks in cells treated with 0.2 M TAS-103 using pulsed field gel electrophoresis. DNA fragments of 1-2 Mb appeared in both HL-60 and HP100 cells treated following a 1-h treatment with TAS-103; smaller fragments appeared at 3 h in HL-60 cells ( Fig. 2A) , suggesting that the 1-2-Mb fragments were further digested to generate 50-kb fragments. DNA ladder formation, characteristic of apoptosis, was detectable at 3 h and significantly increased at 4 h in HL-60 cells; we observed only low levels of DNA ladder s at 5 h with an increase at 6 h in HP100 cells (Fig. 2B) .
Generation of Peroxide in HL-60 and HP100 Cells Treated with TAS-103-We observed peroxide generation in HL-60 and HP100 cells following treatment with TAS-103 (Fig. 3) . Increases in peroxide generation were observed in HL-60 cells at 3 and 4 h, while the generation in HP100 cells was partially suppressed. This result indicates that the peroxide is mainly H 2 O 2 , because catalase activity in HP100 cells is much higher than that in HL-60 cells (26) .
Changes of ⌬⌿m in HL-60 and HP100 Cells Treated with TAS-103-To examine whether TAS-103 induces MPT, we measured changes of ⌬⌿m in HL-60 and HP100 cells treated with TAS-103 (Fig. 4) . treated cells using a fluorometric assay with DEVD-AFC as a substrate. In HL-60 cells, caspase-3 activity increased after a 4 h treatment with TAS-103. In contrast, caspase-3 activation in HP100 cells was observed only after a 5 h treatment with TAS-103 (Fig. 5 ). Caspase-3 activity in HL-60 cells was significantly higher than that seen in HP100 cells at 3-5 h.
Inhibitory Effects of PARP Inhibitors on Apoptotic Process in HL-60 Cells Treated with TAS-103
-PARP is a DNA repair enzyme activated by DNA cleavage (35) (36) (37) . Thus, we investigated the effects of PARP inhibitors, ANI and PHEN, on DNA ladder formation in HL-60 cells treated with TAS-103. ANI and PHEN prevented TAS-103-induced DNA ladder formation (Fig.  6 ). In addition, we analyzed the effects of ANI on peroxide generation and changes in ⌬⌿m following the treatment of HL-60 cells with TAS-103. ANI inhibited peroxide production in HL-60 cells at 3 h (Fig. 7A ) and suppressed increases in ⌬⌿m in HL-60 cells at 4 and 5 h (Fig. 7B) .
Inhibitory Effects of NAD(P)H Oxidase Inhibitors on DNA Ladder Formation in HL-60 Cells Treated with TAS-103-To
identify the enzyme mediating peroxide generation during TAS-103-mediated apoptosis, we investigated the effects of NAD(P)H oxidase inhibitors, DPI (38, 39) and APO (40, 41) , on DNA ladder formation in HL-60 cells. Both DPI and APO prevented TAS-103-mediated DNA ladder formation in HL-60 cells (Fig. 8) . A xanthine oxidase inhibitor, ALLO, did not prevent DNA ladder formation (Fig. 8) , indicating that TAS-103-mediated apoptosis occurs through the activation of NAD(P)H oxidase, but not xanthine oxidase. HL-60 cells treated with TAS-103 to examine PARP function. NAD ϩ levels were significantly decreased at 3 h after TAS-103 treatment. The decrease in NADP ϩ at 2-3 h was delayed compared with that in NAD ϩ by ϳ30 min. Finally, NADP ϩ and NAD ϩ decreased to a similar level at 4 h (Fig. 9) . Thus, decreases in NAD ϩ preceded the increases of ⌬⌿m and the induction of DNA ladder formation. In addition, we analyzed GSH level in HL-60 cells treated with TAS-103. GSH level was significantly decreased at 6 h.
Inhibitory Effect of Bcl-2 on Apoptosis in BJAB Cells Treated with TAS-103-
We investigated the effect of Bcl-2 expression on TAS-103-induced apoptosis using BJAB/Bcl-2 cells by morphologic analysis to examine whether MPT via H 2 O 2 generation participates in TAS-103-induced apoptosis. Apoptosis was observed in TAS-103-treated BJAB/neo cells, whereas it was completely inhibited in BJAB/Bcl-2 cells (Fig. 10) . early events of DNA cleavage to eventual DNA ladder formation (Fig. 11) . DNA cleavage is initiated by TAS-103-mediated inhibition of topoisomerases (1, 2, 4) . Excessive DNA damage causes PARP hyperactivation to repair DNA (35) (36) (37) 42) . PARP inhibitors, ANI and PHEN, prevented DNA ladder formation following TAS-103 treatment of HL-60 cells, indicating that TAS-103-induced apoptosis requires PARP hyperactivation. PARP hyperactivation accelerates the consumption of NAD ϩ , a PARP substrate (36, 37, 42) . NAD ϩ and NADP ϩ levels decreased in HL-60 cells treated with TAS-103 in less than 3 h. The decrease in NADP ϩ at 2-3 h appears to be delayed compared with that in NAD ϩ by ϳ30 min, suggesting that NADP ϩ may be converted to NAD ϩ by phosphatase for the supplementation of NAD ϩ . Relevantly, the interconversion of pyridine nucleotides in such circumstances has previously been reported (43) . Thus, PARP hyperactivation results in the depletion of both NAD ϩ and NADP ϩ . TAS-103 induced apoptosis in both HL-60 and the H 2 O 2 -resistant clone, HP100. DNA cleavage was induced in these cells at 1 h to a similar extent by TAS-103, suggesting that the cleavage is caused by the inhibition of topoisomerases without H 2 O 2 generation. DNA ladder formation in HP100 cells, however, was delayed to 6 h from 4 h in HL-60 parental cells. This delay can be explained by the involvement of H 2 O 2 generation in the apoptotic pathway. In HP100 cells, H 2 O 2 generation, increases in ⌬⌿m and caspase-3 activation were suppressed relative to the levels observed in HL-60 cells. H 2 O 2 formation precedes increases in ⌬⌿m and caspase-3 activation in TAS-103-induced apoptosis; in HL-60 cells, H 2 O 2 generation occurred at 3 h, followed by increases in ⌬⌿m and caspase-3 activation at 4 h (Fig. 11) , whereas in HP100 cells, H 2 generation is critical in these TAS-103-induced apoptotic events. PARP inhibitors inhibited both H 2 O 2 generation at 3 h and changes in ⌬⌿m at 4-5 h in HL-60 cells, indicating that TAS-103-induced PARP hyperactivation is important for H 2 O 2 generation.
Here, the question has been raised how TAS-103 induces generation of H 2 O 2 . On the basis of our data, we propose the possible mechanism by which TAS-103 induces the generation of intracellular H 2 O 2 as follows: the PARP-catalyzed depletion of both NAD ϩ and NADP ϩ in cells treated with TAS-103 may result in the activation of NAD(P)H oxidase to maintain the cellular redox balance by converting NAD(P)H to NAD(P) ϩ (44). NAD(P)H oxidase catalyzes the following reaction:
Ϫ is then rapidly converted to H 2 O 2 (45) . This possibility is supported by our observations that inhibitors of NAD(P)H oxidase inhibited TAS-103-induced DNA ladder formation in HL-60 cells. On the other hand, rotenone, which can inhibit mitochondrial ROS production (46), did not inhibit TAS-103-induced DNA ladder formation (data not shown). This result excludes the possibility that ROS are released from mitochondria. The decreases in intracellular GSH may also induce ROS generation (13, 47) . Significant GSH decreases were not observed until 6 h, suggesting this GSH decrease does not mediate early generation of H 2 O 2 . Therefore, NAD(P)H oxidase is the primary enzyme mediating H 2 O 2 formation in cells treated with TAS-103. In addition, p53 activation by DNA damage induces apoptosis by the transcriptional induction of redox-related genes and the formation of ROS (48, 49) . This possibility is also excluded as HL-60 cells lack functional p53 (50) .
The activation of NAD(P)H oxidase has been reported to either precede (51, 52) or follow (53) caspase-3 activation. TAS-103-induced H 2 O 2 generation was not inhibited by a caspase-3 inhibitor (data not shown), confirming that activation of NAD(P)H oxidase occurs upstream of caspase-3 activation. Our results revealed that H 2 O 2 generation via NAD(P)H oxidase activation precedes the ⌬⌿m increase in TAS-103-induced apoptosis. Bcl-2 binds to the voltage-dependent anion channel to regulate the mitochondrial membrane potential, and controls the release of mitochondrial apoptogenic factors, cytochrome c and apoptosis-inducing factor (AIF), a mitochondrial flavoprotein (54, 55) . Our experiment using BJAB/Bcl-2 cells confirmed that Bcl-2 prevented TAS-103-induced apoptosis by inhibiting MPT mediated by H 2 O 2 generation. AIF has an NADH oxidase activity, but DPI, an NAD(P)H oxidase inhibitor, does not affect the apoptogenic activity of AIF (56) . Our data that DPI prevented TAS-103-induced apoptosis exclude the possibility that the NAD(P)H oxidase activity of AIF is involved in apoptosis. It has been reported that the activity of NAD(P)H oxidase in microsomes is linked to cytosolic NAD(H) redox and appears to be a key source of O 2 Ϫ production (57). Taken together, the activation of microsomal NAD(P)H oxidase may participate in TAS-103-induced H 2 O 2 generation. In conclusion, H 2 O 2 generation precedes MPT, leading to subsequent apoptotic events, including cytochrome c release and caspase-3 activation in TAS-103-induced apoptosis.
